Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2005 Jul 15;15(14):3402-6.

(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitors.

Author information

1
GlaxoSmithKline Pharmaceuticals, Neurology and GI Centre of Excellence for Drug Discovery, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK. Mark_J_Bamford@GSK.com

Erratum in

  • Bioorg Med Chem Lett. 2015 Mar 1;25(5):1151.

Abstract

A novel series of imidazo[4,5-c]pyridines bearing a 1,2,5-oxadiazol-3-ylamine functionality has been developed. These are potent inhibitors of mitogen and stress-activated protein kinase-1.

PMID:
15950465
DOI:
10.1016/j.bmcl.2005.05.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center